TIAM1 variants improve clinical outcome in neuroblastoma

Identification of tumor driver mutations is crucial for improving clinical outcome using a personalized approach to the treatment of cancer. Neuroblastoma is a tumor of the peripheral sympathetic nervous system for which only a few driver alterations have been described including MYCN amplification...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanmartín, Elena, Yáñez, Yania, Fornés-Ferrer, Victoria, Zugaza, José L., Cañete, Adela, Castel, Victoria, de Mora, Jaime Font
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542186/
https://www.ncbi.nlm.nih.gov/pubmed/28423360
http://dx.doi.org/10.18632/oncotarget.16787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542186/
https://www.ncbi.nlm.nih.gov/pubmed/28423360
http://dx.doi.org/10.18632/oncotarget.16787

Ejemplares similares